Literature DB >> 20640893

MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions.

Jérémie H Lefevre1, Chrystelle Colas, Florence Coulet, Carolina Bonilla, Najat Mourra, Jean-Francois Flejou, Emmanuel Tiret, Walter Bodmer, Florent Soubrier, Yann Parc.   

Abstract

MYH associated polyposis is a hereditary syndrome responsible for early colorectal cancer with a distinct genetic pathway from the Familial Adenomatous Polyposis or the Hereditary Non Polyposis Colorectal Cancer syndrome. We have studied a family with three members bearing a biallelic mutation in MYH at c.1185_1186dup. One patient who developed colon cancer had loss of expression of MLH1 on tumoral tissue and microsatellite instability (MSI) phenotype. Analysis of MLH1 based on his blood sample revealed no germline mutation or large genomic deletion. No methylation of the promoter was identified in tumoral DNA. No transversion mutations were identified in APC or KRAS in tumor DNA of this patient. Loss of expression of MLH1 was due to a transversion in intron 7 at position +5 (c.588 + 5G > T) leading to a complete deletion of exon 7 at the RNA level. This observation demonstrates that MLH1 can be a target of MYH transversions leading to MSI phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640893     DOI: 10.1007/s10689-010-9367-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  21 in total

1.  A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.

Authors:  Salud Borrego; Fred A Wright; Raquel M Fernández; Nita Williams; Manuel López-Alonso; Ramana Davuluri; Guillermo Antiñolo; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

2.  Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations in mismatch repair genes in Austrian HNPCC patients.

Authors:  Brigitte Wolf; Silke Gruber; Silvia Henglmueller; Sonja Kappel; Michael Bergmann; Friedrich Wrba; Judith Karner-Hanusch
Journal:  Int J Cancer       Date:  2006-03-15       Impact factor: 7.396

3.  Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.

Authors:  M F Kane; M Loda; G M Gaida; J Lipman; R Mishra; H Goldman; J M Jessup; R Kolodner
Journal:  Cancer Res       Date:  1997-03-01       Impact factor: 12.701

4.  Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.

Authors:  Constanze Pagenstecher; Maria Wehner; Waltraut Friedl; Nils Rahner; Stefan Aretz; Nicolaus Friedrichs; Marlies Sengteller; Wolfram Henn; Reinhard Buettner; Peter Propping; Elisabeth Mangold
Journal:  Hum Genet       Date:  2005-12-08       Impact factor: 4.132

5.  Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.

Authors:  Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle
Journal:  Nat Genet       Date:  2002-01-30       Impact factor: 38.330

6.  Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families.

Authors:  Monika Grabowski; Yvonne Mueller-Koch; Eva Grasbon-Frodl; Udo Koehler; Gisela Keller; Holger Vogelsang; Wolfgang Dietmaier; Reinhard Kopp; Ulrike Siebers; Wolfgang Schmitt; Birgit Neitzel; Maria Gruber; Christa Doerner; Brigitte Kerker; Petra Ruemmele; Gabriele Henke; Elke Holinski-Feder
Journal:  Genet Test       Date:  2005

7.  BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.

Authors:  Guoren Deng; Ian Bell; Suzanne Crawley; James Gum; Jonathan P Terdiman; Brian A Allen; Brindusa Truta; Marvin H Sleisenger; Young S Kim
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

8.  Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.

Authors:  A Hemminki; P Peltomäki; J P Mecklin; H Järvinen; R Salovaara; M Nyström-Lahti; A de la Chapelle; L A Aaltonen
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

9.  Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway.

Authors:  Lara Lipton; Sarah E Halford; Victoria Johnson; Marco R Novelli; Angela Jones; Carole Cummings; Ella Barclay; Oliver Sieber; Amir Sadat; Marie-Luise Bisgaard; Shirley V Hodgson; Lauri A Aaltonen; Huw J W Thomas; Ian P M Tomlinson
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

10.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

Authors:  J M Cunningham; E R Christensen; D J Tester; C Y Kim; P C Roche; L J Burgart; S N Thibodeau
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

View more
  11 in total

1.  Unresectable metastatic colorectal cancer patient cured with cetuximab-based chemotherapy: a case report with new molecular insights.

Authors:  Romain Cohen; Marine Sroussi; Camilla Pilati; Sidney Houry; Pierre Laurent-Puig; Thierry André
Journal:  J Gastrointest Oncol       Date:  2018-08

2.  Reduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer.

Authors:  Rabeah Abbas Al-Temaimi; Sindhu Jacob; Waleed Al-Ali; Diana Ann Thomas; Fahd Al-Mulla
Journal:  J Histochem Cytochem       Date:  2013-06-24       Impact factor: 2.479

3.  Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors.

Authors:  Isabelle Sourrouille; Florence Coulet; Jeremie H Lefevre; Chrystelle Colas; Mélanie Eyries; Magali Svrcek; Armelle Bardier-Dupas; Yann Parc; Florent Soubrier
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

4.  Biallelic MUTYH mutations can mimic Lynch syndrome.

Authors:  Monika Morak; Barbara Heidenreich; Gisela Keller; Heather Hampel; Andreas Laner; Albert de la Chapelle; Elke Holinski-Feder
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

Review 5.  MYH polyposis syndrome: clinical findings, genetics issues and management.

Authors:  M Sereno; M Merino; M López-Gómez; C Gómez-Raposo; F Zambrana Tébar; J Moreno Rubio; J Espinós; S Martín-Algarra; E Casado Sáenz
Journal:  Clin Transl Oncol       Date:  2014-03-19       Impact factor: 3.405

6.  Human POLB gene is mutated in high percentage of colorectal tumors.

Authors:  Katherine A Donigan; Ka-wai Sun; Antonia A Nemec; Drew L Murphy; Xiangyu Cong; Veronika Northrup; Daniel Zelterman; Joann B Sweasy
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

7.  Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.

Authors:  Fadwa A Elsayed; C Marleen Kets; Dina Ruano; Brendy van den Akker; Arjen R Mensenkamp; Melanie Schrumpf; Maartje Nielsen; Juul T Wijnen; Carli M Tops; Marjolijn J Ligtenberg; Hans F A Vasen; Frederik J Hes; Hans Morreau; Tom van Wezel
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

8.  Map syndrome (MYH Associated Polyposis) colorectal cancer, etiopathological connections.

Authors:  A Bolocan; D Ion; R V Stoian; M B Serban
Journal:  J Med Life       Date:  2011-02-25

Review 9.  zzm321990 MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer.

Authors:  Megan L Hutchcraft; Holly H Gallion; Jill M Kolesar
Journal:  Diagnostics (Basel)       Date:  2021-01-06

Review 10.  MUTYH the base excision repair gene family member associated with colorectal cancer polyposis.

Authors:  Seyed Mohammad Hossein Kashfi; Mina Golmohammadi; Faeghe Behboudi; Ehsan Nazemalhosseini-Mojarad; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.